TTE Improves Clinical Management of Stable Chest Pain

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorTianjin Chest Hospital

About this trial

The investigator aims to prospectively enroll patients who were referred for transthorcic echocardiography (TTE) for the assessment of stable chest pain (SCP) suspected of obstructive coronary artery disease (CAD). All patients underwent TTE according to established guidelines and local institutional protocols. This study will determine if TTE-based imaging evaluation can provide more informaton to improve clinical management for SCP, including fewer MACE and better decision-making of downstream investigations and therapeutic interventions.

Eligibility criteria

Qualifiers

symptomatic patients with SCP suspected of obstructive CAD.

referred for TTE for the assessment of SCP.

≥18 years of age.

signed informed consent.

Disqualifiers

acute coronary syndromes

previous CAD or coronary revascularization

nonsinus rhythm

cardiomyopathy, valvular disease, congenital heart disease or left cardiac insufficiency because of other reasons

Trial design

Treatments tested in this trial

  • TTE

Treatment groups

50,000 Participants
are divided into 1 treatment group

Sponsors and collaborators